Skip Navigation LinksHome > June 2012 - Volume 55 - Issue 2 > Hepatitis B: Treatment to Prevent Perinatal Transmission
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e318251097a
Prevention of Infection in the Obstetric Patient

Hepatitis B: Treatment to Prevent Perinatal Transmission


Collapse Box


Hepatitis B remains a significant health issue and a leading cause of cirrhosis and hepatocellular carcinoma worldwide. Transmission of the hepatitis B virus, despite the availability of the vaccine, still occurs, particularly in the perinatal setting. Studies have shown that mothers with active viremia especially those with very high viral levels (>108 copies/mL or >107 IU/mL) are at increased risk of hepatitis B virus transmission, even with appropriate immunoprophylaxis at birth. With the development of new and relatively safe oral antiviral therapies, assessment with the mother about the risks and benefits of antiviral therapy should be discussed in those with highest transmission risk.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.